The CagriSema combination — the most powerful weight loss stack in clinical trials.
The combination of GLP-1 (Semaglutide) and Cagrilintide represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.
GLP-1 (Semaglutide) primarily acts via glp-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite., while Cagrilintide complements this by long-acting amylin analog that activates amylin receptors in the hypothalamus to reduce food intake and slow gastric emptying.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.
GLP-1 (Semaglutide) Targets
Cagrilintide Targets
Systemic effectsStart This Protocol
Alukard provides physician-supervised longevity protocols, including the GLP-1 (Semaglutide) + Cagrilintide stack, with GMP-certified compounds and comprehensive biomarker testing.
Get Physician ConsultationBegin Your Age Reversal Protocol for GLP-1 (Semaglutide) + Cagrilintide Stack
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing